| Stephanie J Landvater, MD | |
|
2418 Airport Rd Ste C, Barre, VT 05641-8702 | |
| (802) 881-5137 | |
| (802) 433-5070 |
| Full Name | Stephanie J Landvater |
|---|---|
| Gender | Female |
| Speciality | Orthopaedic Surgery |
| Location | 2418 Airport Rd Ste C, Barre, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689662215 | NPI | - | NPPES |
| OVN0439 | Medicaid | VT | |
| 1689662215 | Medicaid | VT | |
| 18693 | Other | VT | BLUE CROSS/BLUE SHIELD/VT |
| 18304 | Other | VT | MVP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 042000860 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie J Landvater, MD 507 Chapman Ln, Williston, VT 05495-7770 Ph: (802) 881-5137 | Stephanie J Landvater, MD 2418 Airport Rd Ste C, Barre, VT 05641-8702 Ph: (802) 881-5137 |
News Archive
How do we assess the current and future quality of life for infants and children with life-threatening conditions? In the April issue of Current Problems in Pediatric and Adolescent Health Care, "The Quality of Life of Young Children and Infants with Chronic Medical Problems," presents a collection of essays in which physicians, medical ethicists, parents, and caregivers address one of the most contentious topics in pediatric and clinical ethics today, the assessment of QoL.
Finding that the availability of menthol cigarettes increases the number of children and African Americans who smoke, the Food and Drug Administration's Tobacco Products Scientific Advisory Committee today concluded, "Removal of menthol cigarettes from the marketplace would benefit public health in the United States."
Scientists from the Florida campus of The Scripps Research Institute have been awarded nearly $2.2 million by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to advance an innovative approach to the treatment of obesity, a serious health problem that affects more than one-third of all Americans.
Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body's own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.
Pfizer Inc. and Medivation, Inc. today announced results from two Phase 3 trials of the investigational drug dimebon (latrepirdine) in patients with Alzheimer's disease (AD). In the CONNECTION trial, dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of cognition and global function.
› Verified 4 days ago
John Begly, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Cvmc Orthopaedics & Sports Medicine, 1311 Barre-montpelier Road Suit 400, Barre, VT 05602 Phone: 802-225-3970 |